BioPharma Dive ٨ ديسمبر ٢٠٢٥ Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
BioPharma Dive ٢٦ نوفمبر ٢٠٢٥ Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3